Pharmacy World and Science

, Volume 27, Issue 1, pp 7–12 | Cite as

The argument for pharmaceutical policy

  • Janine Morgall TraulsenEmail author
  • Anna Birna Almarsdóttir


Pharmaceutical policy is a global concern. It has become a hot political topic in most countries – developed as well as developing – and can be found on the agenda of international organizations such as WHO, OECD, EU, WTO and even the World Bank. Pharmaceutical policy affects everyone in the world of pharmacy and it is therefore imperative that it be understood, discussed and debated within the pharmacy profession and included in the curriculum of schools of pharmacy. This, the first article in a series, argues for the importance of the academic discipline of pharmaceutical policy analysis and the involvement of pharmacists in this endeavour. The aim of the authors is to stimulate an informed and critical appreciation of this field. The authors begin with an introduction to the field of pharmaceutical policy, introducing several important concepts and current trends including: medicines regulation; how pharmaceutical policy is made; pharmaceutical policy as a dynamic process; and the new public health as a global issue. The article ends with a short description of the remaining five articles in the series which will deal with important aspects of pharmaceutical policy. The topics include: economic pressures on health care systems; drug utilization from the clinical viewpoint (rational use of medicines); the impact of pharmaceutical policy on patients and the patient impact on pharmaceutical policy; the professional perspective; and finally the last article which deals with studying and evaluating pharmaceutical policy.


Health care Pharmaceutical policy Pharmacy administration  


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Andersen NV. The community pharmacy monopoly up for debate in the Folketing (Danish Parliament) [in Danish]. Politiken daily newspaper, Saturday 19 June 2004.Google Scholar
  2. Larsen JB, Traulsen JM. The liberalization that didn’t come [in Danish]. Lægemiddelforskning (the Bulletin of the Danish University of Pharmaceutical Sciences) 2003; 36–7.Google Scholar
  3. Larsen, JB 2004The pharmaceutical distribution in Denmark–viewed in the light of deregulation.The Danish University of Pharmaceutical Sciences, Department of Social PharmacyCopenhagenGoogle Scholar
  4. Anell, A, Hjelmgren, J 2001The effects of deregulating community pharmacy – experiences from Iceland, Norway, and Denmark [in Swedish].The Swedish Institute for Health Economics (IHE)LundIHE working report no. 2001:3.Google Scholar
  5. Anell A. The effects of deregulating community pharmacy–experiences from Iceland, Norway, and Denmark [in Swedish]. IHE working report. Lund: The Swedish Institute for Health Economics (IHE), in press.Google Scholar
  6. Mathisen, G 2004Disagreement on foreign ownership [in Norwegian].Norges Apotekerforenings Tidsskrift0146Google Scholar
  7. Strøm, S 2004The community pharmacy reform [in Norwegian].Norges Apotekerforenings Tidsskrift0189Google Scholar
  8. ECON Analyse2004Evaluation of the pharmaceutical legislation and the index price system.ECON AnalyseOsloECON-report no. 2004-10. ISBN 82-7645-686-3.Google Scholar
  9. Brekke, KR, Grasdal, A, Holmås, TH, Steen, F, Sunnevåg, K 2003Evaluation of new pharmaceutical legislation and the index price system [in Norwegian].RokkansenteretBergenISBN 82-0895-021-4.Google Scholar
  10. McKinlay, J, Arches, J 1985Towards the proletarianization of physicians.Int J Health Serv1516195PubMedGoogle Scholar
  11. Traulsen, JM, Bissell, P 2004Theories of professions and the pharmacist.Int J Pharm Pract1210714Google Scholar
  12. Hepler, CD, Strand, LM 1991Opportunities and responsibilities in pharmaceutical care.Am J Hosp Pharm4753343Google Scholar
  13. Cipolle, RJ, Strand, LM, Morley, PC 1998Pharmaceutical care practice.McGraw HillNew YorkGoogle Scholar
  14. Brekke, KR, Grasdal, A, Holmås, TH, Steen, F, Sunnevåg, K 2004Evaluation of new pharmaceutical legislation and the index price system [in Norwegian].Norges Apotekerforenings Tidsskrift01125Google Scholar
  15. Gabe, J, Bury, M, Elston, MA 2004Key concepts in medical sociology.Sage PublicationsLondonISBN 0-7619-7441-5.Google Scholar
  16. Davis, P 1997Managing medicines: public policy and therapeutic drugs.Open University PressBuckinghamISBN 0-335-19292-0.Google Scholar
  17. Abraham, J, Lewis, G 2002Citizenship, medical expertise and the capitalist regulatory state in Europe.Sociology366788Google Scholar
  18. Abraham, J 1997The science and politics of medicines regulationElston, M eds. The sociology of medical science and technology.Blackwell PublishingOxfordGoogle Scholar
  19. Johnson, JA, Bootman, JL 1995Drug-related morbidity and mortality.A cost-of-illness model. Arch Intern Med155194956Google Scholar
  20. McKeown, T 1979The role of medicine: dream, mirage or nemesis?Blackwell PublishingOxfordGoogle Scholar
  21. 21, Fidler DP 2001The globalization of public health: the first 100 years of international health diplomacy.Bull. World Health Organ798429PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Janine Morgall Traulsen
    • 1
    Email author
  • Anna Birna Almarsdóttir
    • 2
  1. 1.Department of Social PharmacyThe Danish University of Pharmaceutical SciencesCopenhagen ØDenmark
  2. 2.Faculty of Pharmacy, and AL-BAS Pharmaceutical Consultants LtdUniversity of IcelandReykjavikIceland

Personalised recommendations